Concord Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Sell
19,775
-402
-2% -$93.7K 0.58% 38
2026
Q1
$4.93M Buy
20,177
+287
+1% +$66.8K 0.64% 34
2025
Q4
$4.12M Buy
19,890
+201
+1% +$39.7K 0.53% 37
2025
Q3
$3.65M Sell
19,689
-1,156
-6% -$198K 0.5% 39
2025
Q2
$3.18M Sell
20,845
-2,216
-10% -$341K 0.46% 48
2025
Q1
$3.82M Sell
23,061
-155
-0.7% -$24.3K 0.63% 36
2024
Q4
$3.36M Sell
23,216
-3,524
-13% -$546K 0.55% 42
2024
Q3
$4.33M Buy
26,740
+449
+2% +$71.5K 0.72% 38
2024
Q2
$3.84M Sell
26,291
-1,163
-4% -$173K 0.68% 39
2024
Q1
$4.34M Buy
27,454
+2,292
+9% +$365K 0.78% 32
2023
Q4
$3.94M Buy
25,162
+4,131
+20% +$633K 0.79% 30
2023
Q3
$3.28M Buy
21,031
+1,973
+10% +$326K 0.7% 28
2023
Q2
$3.15M Buy
19,058
+6,019
+46% +$971K 0.68% 30
2023
Q1
$2.02M Buy
13,039
+4,679
+56% +$756K 0.57% 30
2022
Q4
$1.48M Sell
8,360
-2,854
-25% -$493K 0.44% 36
2022
Q3
$1.83M Sell
11,214
-344
-3% -$58.2K 0.58% 31
2022
Q2
$2.05M Sell
11,558
-369
-3% -$65.7K 0.56% 31
2022
Q1
$2.11M Buy
11,927
+589
+5% +$100K 0.55% 29
2021
Q4
$1.94M Buy
11,338
+7,075
+166% +$1.16M 0.47% 29
2021
Q3
$688K Sell
4,263
-5,334
-56% -$910K 0.28% 27
2021
Q2
$1.58M Buy
9,597
+803
+9% +$133K 0.45% 20
2021
Q1
$1.45M Buy
8,794
+4,548
+107% +$736K 0.49% 20
2020
Q4
$668K Buy
+4,246
New +$627K 0.52% 23

Other funds holding JNJ

Concord Wealth Partners's JNJ Position: Q2 2026 in Review

Concord Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 2% in Q2 2026, selling an estimated $93.7K and leaving 19,775 shares worth $5.02M. The position accounts for 0.58% of the portfolio, ranked #38.

Concord Wealth Partners first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Concord Wealth Partners held 19,775 shares of Johnson & Johnson worth $5.02M as of Q2 2026.
  • Concord Wealth Partners sold 402 Johnson & Johnson shares in Q2 2026, an estimated $93.7K.
  • Johnson & Johnson made up 0.58% of Concord Wealth Partners's portfolio in Q2 2026, its #38 holding.
  • Concord Wealth Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.